New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases

Dyslipidemia, characterized by elevation of plasma low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and reduction of plasma high density lipoprotein cholesterol (HDL-C), has been verified as a causal risk factor for cardiovascular diseases (CVD), leading to a high mortality rate in gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xin, Peng, Dao-quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769531/
https://www.ncbi.nlm.nih.gov/pubmed/29334984
http://dx.doi.org/10.1186/s12944-018-0659-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769531/
https://www.ncbi.nlm.nih.gov/pubmed/29334984
http://dx.doi.org/10.1186/s12944-018-0659-y

Ejemplares similares